Extensive literature reviews indicate CYB5D2 exerts tumor-suppressive effects across multiple malignancies, including breast cancer, hepatocellular carcinoma, lung cancer, and clear cell renal cell carcinoma (ccRCC). Here, CYB5D2 is linked to hepatocellular carcinoma.